CLOV vs IBO
Clover Health Investments Corp (CLOV) versus Impact BioMedical, Inc. (IBO) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
CLOV currently screens at market cap $1.55B. IBO currently screens at market cap $7.6M.
Not investment advice. Open the CLOV and IBO stock pages for the full models.
Not investment advice.